{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Trusha Adeshara",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Diagnosis of multiple sclerosis: progress and challenges",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "NCIT": "^C\\d+$",
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/3c93a65dc48e6786fe29ae55aa36cf9a902fe8c6/export/conso-names.belns",
      "DOID": "https://raw.githubusercontent.com/pharmacome/conso/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/drugbank-names.belns",
      "EFO": "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/hp-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns"
    },
    "path": "ms/brownlee2016.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "It can present with changes in sensation, mobility, balance, sphincter function, vision, and cognition.",
      "key": "12b17d37e7b199e22f40a68db79b500b",
      "line": 79,
      "relation": "association",
      "source": 23,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "It can present with changes in sensation, mobility, balance, sphincter function, vision, and cognition.",
      "key": "8abed4301abb61df7e55b23ecc80576a",
      "line": 80,
      "relation": "association",
      "source": 23,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "It can present with changes in sensation, mobility, balance, sphincter function, vision, and cognition.",
      "key": "56c6fd2563468b1e6e6f439da714575c",
      "line": 81,
      "relation": "association",
      "source": 23,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "It can present with changes in sensation, mobility, balance, sphincter function, vision, and cognition.",
      "key": "42da348d49d6b5507b1e2f7a92ca4aed",
      "line": 83,
      "relation": "association",
      "source": 23,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "It can present with changes in sensation, mobility, balance, sphincter function, vision, and cognition.",
      "key": "a5a3b1641af0d4cf516633c1de5dce8b",
      "line": 84,
      "relation": "association",
      "source": 23,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "It can present with changes in sensation, mobility, balance, sphincter function, vision, and cognition.",
      "key": "780b15a7b692cc79daa07b1a3db8b8bb",
      "line": 85,
      "relation": "association",
      "source": 23,
      "target": 3
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "CSF findings include a normal or mildly raised white cell count (<25 cells per cm³; predominantly lymphocytes) and protein (usually <1 g/L), a raised IgG index, and IgG oligoclonal bands not present in serum.14",
      "key": "f1f266f709beac64861e9ee8aed2a0a7",
      "line": 148,
      "relation": "increases",
      "source": 23,
      "target": 4
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "CSF findings include a normal or mildly raised white cell count (<25 cells per cm³; predominantly lymphocytes) and protein (usually <1 g/L), a raised IgG index, and IgG oligoclonal bands not present in serum.14",
      "key": "70bb7ba8447eb3b9fb88d6f423e6bbe8",
      "line": 149,
      "relation": "increases",
      "source": 23,
      "target": 13
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "CSF findings include a normal or mildly raised white cell count (<25 cells per cm³; predominantly lymphocytes) and protein (usually <1 g/L), a raised IgG index, and IgG oligoclonal bands not present in serum.14",
      "key": "51fdf29e3ebd03e399dcb9bcb3dc1dda",
      "line": 150,
      "relation": "increases",
      "source": 23,
      "target": 12
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true,
          "spinal cord": true
        },
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Younger age, male sex, and gadolinium enhancing, cortical, or spinal cord lesions might be associated with an increased risk of developing multiple sclerosis.29–31 ",
      "key": "131be87d12dce53cd90dceb6b45fe0fd",
      "line": 169,
      "relation": "positiveCorrelation",
      "source": 23,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": " A diagnosis of multiple sclerosis should only be made in a patient who has symptoms suggestive of demyelination.[2]",
      "key": "5d55aadcd87c8195691d2ddb5bbb5f91",
      "line": 176,
      "relation": "increases",
      "source": 23,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In younger children (<12 years of age) multiple sclerosis can present differently from in adolescents and adults; encephalopathy, multifocal neurological deficits (often with prominent brainstem or cerebellar involvement), and seizures are more common.[32]",
      "key": "a9f118a631e0a4c2c8eb21c2f8b69e5b",
      "line": 231,
      "relation": "increases",
      "source": 23,
      "target": 46
    },
    {
      "annotations": {
        "Anatomy": {
          "brainstem": true,
          "cerebellum": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In younger children (<12 years of age) multiple sclerosis can present differently from in adolescents and adults; encephalopathy, multifocal neurological deficits (often with prominent brainstem or cerebellar involvement), and seizures are more common.[32]",
      "key": "00ad7fddf82be3c63640d69f7efbfec7",
      "line": 233,
      "relation": "increases",
      "source": 23,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In younger children (<12 years of age) multiple sclerosis can present differently from in adolescents and adults; encephalopathy, multifocal neurological deficits (often with prominent brainstem or cerebellar involvement), and seizures are more common.[32]",
      "key": "34ff2f729229e67632b92e32a8b54810",
      "line": 235,
      "relation": "increases",
      "source": 23,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "These disorders include several closely related idiopathic inflammatory CNS diseases (tables 1, 2), along with a range of other disorders that can involve white matter (eg, inherited leukodystrophies, vasculopathies, and metabolic disorders), and other neuroinflammatory diseases (eg, sarcoidosis, vasculitis, and Behcet’s disease).",
      "key": "286926762deb21f2ebc3c472810ae2d1",
      "line": 241,
      "relation": "association",
      "source": 23,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "These disorders include several closely related idiopathic inflammatory CNS diseases (tables 1, 2), along with a range of other disorders that can involve white matter (eg, inherited leukodystrophies, vasculopathies, and metabolic disorders), and other neuroinflammatory diseases (eg, sarcoidosis, vasculitis, and Behcet’s disease).",
      "key": "35e02ebea09cf10a67ef2110b41b88f2",
      "line": 242,
      "relation": "association",
      "source": 23,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "These disorders include several closely related idiopathic inflammatory CNS diseases (tables 1, 2), along with a range of other disorders that can involve white matter (eg, inherited leukodystrophies, vasculopathies, and metabolic disorders), and other neuroinflammatory diseases (eg, sarcoidosis, vasculitis, and Behcet’s disease).",
      "key": "9208d484a3e99fee6160dc9db44404da",
      "line": 243,
      "relation": "association",
      "source": 23,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "These disorders include several closely related idiopathic inflammatory CNS diseases (tables 1, 2), along with a range of other disorders that can involve white matter (eg, inherited leukodystrophies, vasculopathies, and metabolic disorders), and other neuroinflammatory diseases (eg, sarcoidosis, vasculitis, and Behcet’s disease).",
      "key": "481d78ed4285867cabfc05e4a421196e",
      "line": 244,
      "relation": "association",
      "source": 23,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "These disorders include several closely related idiopathic inflammatory CNS diseases (tables 1, 2), along with a range of other disorders that can involve white matter (eg, inherited leukodystrophies, vasculopathies, and metabolic disorders), and other neuroinflammatory diseases (eg, sarcoidosis, vasculitis, and Behcet’s disease).",
      "key": "c1e3ff4395907bbab8837e34dca2c6e9",
      "line": 245,
      "relation": "association",
      "source": 23,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "These disorders include several closely related idiopathic inflammatory CNS diseases (tables 1, 2), along with a range of other disorders that can involve white matter (eg, inherited leukodystrophies, vasculopathies, and metabolic disorders), and other neuroinflammatory diseases (eg, sarcoidosis, vasculitis, and Behcet’s disease).",
      "key": "bb8d968646743eca1ad3a14d933af23f",
      "line": 246,
      "relation": "association",
      "source": 23,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "These disorders include several closely related idiopathic inflammatory CNS diseases (tables 1, 2), along with a range of other disorders that can involve white matter (eg, inherited leukodystrophies, vasculopathies, and metabolic disorders), and other neuroinflammatory diseases (eg, sarcoidosis, vasculitis, and Behcet’s disease).",
      "key": "c4184d1f6553a49480a9b7088a94c384",
      "line": 247,
      "relation": "association",
      "source": 23,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "It can present with changes in sensation, mobility, balance, sphincter function, vision, and cognition.",
      "key": "b974db639247b83db62cbc6f9dd3e010",
      "line": 79,
      "relation": "association",
      "source": 7,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "It can present with changes in sensation, mobility, balance, sphincter function, vision, and cognition.",
      "key": "18c38ba703a2d12a46bf57f722cdb52e",
      "line": 80,
      "relation": "association",
      "source": 59,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "It can present with changes in sensation, mobility, balance, sphincter function, vision, and cognition.",
      "key": "70adbdcfa1604021d47e40d8fa0d9ba5",
      "line": 81,
      "relation": "association",
      "source": 5,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "It can present with changes in sensation, mobility, balance, sphincter function, vision, and cognition.",
      "key": "87dd412a8a1fb0f96c3243b7c07c062f",
      "line": 83,
      "relation": "association",
      "source": 1,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "It can present with changes in sensation, mobility, balance, sphincter function, vision, and cognition.",
      "key": "dea1f6a74b87f92a53ca84cfdbe2c35c",
      "line": 84,
      "relation": "association",
      "source": 6,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "It can present with changes in sensation, mobility, balance, sphincter function, vision, and cognition.",
      "key": "4a5ba8e7c669adeaca2497eda3d59186",
      "line": 85,
      "relation": "association",
      "source": 3,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": " The clinical, imaging, and laboratory features of acute disseminated encephalomyelitis and multiple sclerosis overlap and diagnostic criteria emphasise the requirement of encephalopathy (altered level of consciousness, behavioural, or cognitive change) in making the diagnosis of acute disseminated encephalomyelitis (appendix). [32] ",
      "key": "9f4b221fefdf508298f4e892f3577a0b",
      "line": 269,
      "relation": "association",
      "source": 3,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "People with relapsing-remitting multiple sclerosis may develop a progressive course with time (secondary progressive multiple sclerosis) with a gradual increase in disability with or without relapses.[2]",
      "key": "d807faefac640d2d12cd42700c344b37",
      "line": 90,
      "relation": "increases",
      "source": 28,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "f07816661e720b2299d57114ac44b02a",
      "line": 113,
      "relation": "association",
      "source": 28,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "fdf68c7c6de57cd00d0ee3ac6ebe7b79",
      "line": 114,
      "relation": "association",
      "source": 28,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "94960e4c7fbdd710f6e90731354aaa38",
      "line": 115,
      "relation": "association",
      "source": 28,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "1de09061e01fa5f9cbe93a5c9c3d3cb6",
      "line": 116,
      "relation": "association",
      "source": 28,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "3f8818c11dbb3375c68374792a82be95",
      "line": 117,
      "relation": "association",
      "source": 28,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "3bda143a9f9385c4fb1ee630a1eb6ca0",
      "line": 118,
      "relation": "association",
      "source": 28,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "38bac2e97b207109f91250f307693089",
      "line": 119,
      "relation": "association",
      "source": 28,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "4b88a5576f512093dc50e54d4e8ff04a",
      "line": 120,
      "relation": "association",
      "source": 28,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "0c52978cd1f1b0d182e539aa715b7794",
      "line": 121,
      "relation": "association",
      "source": 28,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": " A first episode of neurological dysfunction, presumably due to relapsing-remitting multiple sclerosis, is called a clinically isolated syndrome.[2,5]",
      "key": "11f00d26e4a42b5eba83b3b7f06d863b",
      "line": 126,
      "relation": "positiveCorrelation",
      "source": 28,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "People with relapsing-remitting multiple sclerosis may develop a progressive course with time (secondary progressive multiple sclerosis) with a gradual increase in disability with or without relapses.[2]",
      "key": "49bb7de0bbcde6a408577ef34e525acb",
      "line": 92,
      "relation": "increases",
      "source": 29,
      "target": 75
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Diagnosis is based on the presence of clinical symptoms and signs and findings on MRI, which is highly sensitive to detect characteristic CNS lesions.1",
      "key": "9e9a8855493075137c1d493a87df3a68",
      "line": 99,
      "relation": "prognosticBiomarkerFor",
      "source": 54,
      "target": 23
    },
    {
      "annotations": {
        "Anatomy": {
          "brain gray matter": true,
          "cortex": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Cortical grey matter is frequently involved in multiple sclerosis pathologically, but cortical lesions are rarely visualised on conventional MRI sequences and are better seen using double inversion recovery (DIR) or phase-sensitive inversion recovery (PSIR) techniques.73,75 ",
      "key": "9cc9e5ce794f6d9bc6fd4817f152b367",
      "line": 307,
      "relation": "prognosticBiomarkerFor",
      "source": 54,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "A major discovery was the association between neuromyelitis optica spectrum disorder and serum aquaporin 4 IgG (AQP4-IgG), confirming that it is a different disease from multiple sclerosis and needs distinct treatment.[4]",
      "key": "9fa6ed6b349d290c14695f36bafc7b69",
      "line": 105,
      "relation": "association",
      "source": 24,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "e921f79dc20a008d0e18cff20c27898b",
      "line": 222,
      "relation": "increases",
      "source": 24,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The core clinical features of neuromyelitis optica spectrum disorder are optic neuritis and transverse myelitis.",
      "key": "38f6faae84ff8e5ac21b27a2c016dfe3",
      "line": 283,
      "relation": "positiveCorrelation",
      "source": 24,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "95ee2e2a63d57c8d7ff2673149624ae0",
      "line": 223,
      "relation": "decreases",
      "source": 24,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "0333977704bd736da3adf96fd434956b",
      "line": 224,
      "relation": "increases",
      "source": 24,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The core clinical features of neuromyelitis optica spectrum disorder are optic neuritis and transverse myelitis.",
      "key": "9ee86100de2ea87ac8fbb254aa457112",
      "line": 284,
      "relation": "positiveCorrelation",
      "source": 24,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "71c617cf7b94dec81ff5a08a52489f37",
      "line": 225,
      "relation": "increases",
      "source": 24,
      "target": 43
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Cell": {
          "astrocyte": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Neuromyelitis optica spectrum disorder is an inflammatory astrocytopathy of the CNS with clinical and radiological features that overlap with multiple sclerosis. [4]",
      "key": "2f22d008ef0ffa51c15a292448e5d761",
      "line": 276,
      "relation": "increases",
      "source": 24,
      "target": 72
    },
    {
      "annotations": {
        "Anatomy": {
          "optic chiasma": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Characteristic lesions are those extending over more than half the length of the optic nerve, and sometimes into the optic chiasm. [49,50]",
      "key": "b934201b09c9fe6605a6fb92543639d2",
      "line": 290,
      "relation": "increases",
      "source": 24,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "About 70% of patients with relapsing neuromyelitis optica spectrum disorder are AQP4-IgG-positive, with the sensitivity increased with the use of cell-based rather than ELISA assays.[53,54] ",
      "key": "d35ebb75b7e3b691858883aff8e2efc3",
      "line": 296,
      "relation": "increases",
      "source": 24,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "A major discovery was the association between neuromyelitis optica spectrum disorder and serum aquaporin 4 IgG (AQP4-IgG), confirming that it is a different disease from multiple sclerosis and needs distinct treatment.[4]",
      "key": "3e384551f9da830054a8c1fc4819fa10",
      "line": 105,
      "relation": "association",
      "source": 9,
      "target": 24
    },
    {
      "key": "865e801e54bc0653fa308aa7d8086642",
      "relation": "partOf",
      "source": 8,
      "target": 9
    },
    {
      "key": "c9d5f1ec25fac660b7c603f587d71462",
      "relation": "partOf",
      "source": 11,
      "target": 9
    },
    {
      "key": "26ca4d1676ab7e9b35a413c8813b5647",
      "relation": "partOf",
      "source": 11,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "698856e6edd99bfd4d04e23cc043f825",
      "line": 113,
      "relation": "association",
      "source": 25,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Common clinically isolated syndrome presentations include acute unilateral optic neuritis, a partial myelitis, or a brainstem syndrome.[5]",
      "key": "56330eb7e9b3aafdba6397e26bab4cd6",
      "line": 131,
      "relation": "isA",
      "source": 25,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Common clinically isolated syndrome presentations include acute unilateral optic neuritis, a partial myelitis, or a brainstem syndrome.[5]",
      "key": "c1d18691474318d33366ef3a4b977c50",
      "line": 132,
      "relation": "isA",
      "source": 25,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Common clinically isolated syndrome presentations include acute unilateral optic neuritis, a partial myelitis, or a brainstem syndrome.[5]",
      "key": "8fb1e99d8f92844b3100b5d30d685b45",
      "line": 133,
      "relation": "isA",
      "source": 25,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The core clinical features of neuromyelitis optica spectrum disorder are optic neuritis and transverse myelitis.",
      "key": "3c1d41da158d8bc6a06e514ca8f14616",
      "line": 283,
      "relation": "positiveCorrelation",
      "source": 25,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "3a24fab3b94d5e58ceef4cf2666651a5",
      "line": 114,
      "relation": "association",
      "source": 21,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "65c56ddc915de8cb1cff70ce046e704e",
      "line": 115,
      "relation": "association",
      "source": 31,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "28541c898b8c6d69884b09705511b60d",
      "line": 116,
      "relation": "association",
      "source": 20,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "8386207dda369bb8c67599e970526bdc",
      "line": 117,
      "relation": "association",
      "source": 26,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "2fe2a2b39f7a42c9cc283b8f4a5d26c6",
      "line": 118,
      "relation": "association",
      "source": 49,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "27b81ba40c82116676c2a3f7a301b245",
      "line": 119,
      "relation": "association",
      "source": 42,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "ddf87613863e45fa6f6ddeb14566fef4",
      "line": 120,
      "relation": "association",
      "source": 39,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Panel 1 shows some common presenting symptoms and signs of multiple sclerosis and selected others that are less common and suggestive of an alternative diagnosis.",
      "key": "634cdb5706e9384cb2ad6a1ba60cbc3c",
      "line": 121,
      "relation": "association",
      "source": 58,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": " A first episode of neurological dysfunction, presumably due to relapsing-remitting multiple sclerosis, is called a clinically isolated syndrome.[2,5]",
      "key": "ea2d1dc43e72594db9ac8f0583364888",
      "line": 126,
      "relation": "positiveCorrelation",
      "source": 57,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The core clinical features of neuromyelitis optica spectrum disorder are optic neuritis and transverse myelitis.",
      "key": "af164f379eef37c9ea8c9a0231cfb1c1",
      "line": 284,
      "relation": "positiveCorrelation",
      "source": 35,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The onset of primary progressive multiple sclerosis by contrast is characterised by slowly progressive symptoms, most often an asymmetric paraparesis that evolves over months or years,6 or, less commonly, a progressive hemiparesis or cerebellar ataxia or very rarely, visual failure or dementia.[6]",
      "key": "4a5897b28395ad8d3ddac04e8728a915",
      "line": 138,
      "relation": "increases",
      "source": 27,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The onset of primary progressive multiple sclerosis by contrast is characterised by slowly progressive symptoms, most often an asymmetric paraparesis that evolves over months or years,6 or, less commonly, a progressive hemiparesis or cerebellar ataxia or very rarely, visual failure or dementia.[6]",
      "key": "b9e34cc6fc3f439082a8351f7ced6fc3",
      "line": 139,
      "relation": "increases",
      "source": 27,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The onset of primary progressive multiple sclerosis by contrast is characterised by slowly progressive symptoms, most often an asymmetric paraparesis that evolves over months or years,6 or, less commonly, a progressive hemiparesis or cerebellar ataxia or very rarely, visual failure or dementia.[6]",
      "key": "f4be712745646b6a147097e57c66bf59",
      "line": 140,
      "relation": "increases",
      "source": 27,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The onset of primary progressive multiple sclerosis by contrast is characterised by slowly progressive symptoms, most often an asymmetric paraparesis that evolves over months or years,6 or, less commonly, a progressive hemiparesis or cerebellar ataxia or very rarely, visual failure or dementia.[6]",
      "key": "91a72b1d018f2fa26d7dcfc2802a1e59",
      "line": 141,
      "relation": "increases",
      "source": 27,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The onset of primary progressive multiple sclerosis by contrast is characterised by slowly progressive symptoms, most often an asymmetric paraparesis that evolves over months or years,6 or, less commonly, a progressive hemiparesis or cerebellar ataxia or very rarely, visual failure or dementia.[6]",
      "key": "592e8dabf43bc5a15c070f9ccc5eacef",
      "line": 142,
      "relation": "decreases",
      "source": 27,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The McDonald criteria provide separate recommendations for the diagnosis of primary progressive multiple sclerosis, which includes testing for CSF abnormalities in addition to MRI.[1]",
      "key": "0b3bfa4d23337149cad8a429fcae1e42",
      "line": 161,
      "relation": "increases",
      "source": 27,
      "target": 38
    },
    {
      "key": "88900c5229b8f00bc83ee23fbc111072",
      "relation": "partOf",
      "source": 12,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Oligoclonal bands can sometimes be present in patients with other neuroinflammatory disorders and their presence needs to be interpreted carefully.",
      "key": "f609e0029c65a7424bc77d2a836e9b53",
      "line": 156,
      "relation": "increases",
      "source": 14,
      "target": 0
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true,
          "spinal cord": true
        },
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Younger age, male sex, and gadolinium enhancing, cortical, or spinal cord lesions might be associated with an increased risk of developing multiple sclerosis.29–31 ",
      "key": "024724abb5f9fb70d66b34e899fd7349",
      "line": 169,
      "relation": "positiveCorrelation",
      "source": 63,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "However, spinal cord lesions can be very helpful in making a diagnosis of multiple sclerosis (cord lesions do not occur with healthy ageing or cerebrovascular disease [11] and provide additional evidence of dissemination in space [10]) and might provide important prognostic information.[67]",
      "key": "620a0992b705698fddaafa01d845c18d",
      "line": 301,
      "relation": "prognosticBiomarkerFor",
      "source": 63,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "bd23fa37d19ce350360e2bd9deb093e4",
      "line": 188,
      "relation": "increases",
      "source": 61,
      "target": 67
    },
    {
      "annotations": {
        "Anatomy": {
          "brain white matter": true
        },
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "36dd9a51969c0d613ab6d511760a5303",
      "line": 190,
      "relation": "increases",
      "source": 61,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "f4666774fed9c63eccf5c02316f22585",
      "line": 193,
      "relation": "increases",
      "source": 15,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "99bd10eb309beda80262ce9000b43346",
      "line": 194,
      "relation": "increases",
      "source": 15,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Genitalia": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "1123fbd7d4d5c1cb73de6bfb6423f883",
      "line": 196,
      "relation": "increases",
      "source": 15,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "These disorders include several closely related idiopathic inflammatory CNS diseases (tables 1, 2), along with a range of other disorders that can involve white matter (eg, inherited leukodystrophies, vasculopathies, and metabolic disorders), and other neuroinflammatory diseases (eg, sarcoidosis, vasculitis, and Behcet’s disease).",
      "key": "40c3ea80ccf3504668b7e5ce22db3cbd",
      "line": 247,
      "relation": "association",
      "source": 15,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "fed05dfd9da55ccd8f9f9e5f22edb870",
      "line": 198,
      "relation": "increases",
      "source": 30,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "b9b514bf09390f5333029c51a40ef826",
      "line": 201,
      "relation": "increases",
      "source": 30,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "65453970a8e6c4e78aaadb947d3e648e",
      "line": 204,
      "relation": "increases",
      "source": 30,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "743b2b8c8543c7f035b79f17c41088b5",
      "line": 199,
      "relation": "increases",
      "source": 16,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "5f59e21bba1ceb6ce318b7de11508c9f",
      "line": 202,
      "relation": "increases",
      "source": 16,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "d78c321db766139f1812f981f8a2d7bb",
      "line": 205,
      "relation": "increases",
      "source": 16,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "b58c584f97c5a1bde0c27b99c4e2ce92",
      "line": 200,
      "relation": "increases",
      "source": 18,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "93bc6c5bd16a14a135a156419115538a",
      "line": 203,
      "relation": "increases",
      "source": 18,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "3edf813140e7bed7f56760e1d5c25b44",
      "line": 206,
      "relation": "increases",
      "source": 18,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "a9aa79ca9dc07bac78ceaec46939b02a",
      "line": 207,
      "relation": "increases",
      "source": 18,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "ce4a22018f1efc1405242a74c3a6da9f",
      "line": 208,
      "relation": "increases",
      "source": 32,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "de31a55dcbc66444923fcbd33283836a",
      "line": 209,
      "relation": "increases",
      "source": 32,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "2315296b591374673a44e178bfea6c00",
      "line": 210,
      "relation": "increases",
      "source": 32,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "5e216e85245d20c419192f0f9716190f",
      "line": 211,
      "relation": "increases",
      "source": 32,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "2f90551841602fa78a75414b14e794f4",
      "line": 212,
      "relation": "increases",
      "source": 64,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "f9e83d46fba424807deb8248570352e0",
      "line": 213,
      "relation": "decreases",
      "source": 64,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "346b229f5b44f54a98a3f5fb80ab27b5",
      "line": 214,
      "relation": "increases",
      "source": 64,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "15b8fa48a0edc0490824cdd6c64397a8",
      "line": 215,
      "relation": "increases",
      "source": 19,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "fdee0cb374a82d8a644f9f337e7a3028",
      "line": 216,
      "relation": "increases",
      "source": 19,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "3f82e3554a13d4f03501609e9161f998",
      "line": 217,
      "relation": "increases",
      "source": 19,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "6e81010f9d54128c40771f956fca9f6e",
      "line": 218,
      "relation": "decreases",
      "source": 19,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "These disorders include several closely related idiopathic inflammatory CNS diseases (tables 1, 2), along with a range of other disorders that can involve white matter (eg, inherited leukodystrophies, vasculopathies, and metabolic disorders), and other neuroinflammatory diseases (eg, sarcoidosis, vasculitis, and Behcet’s disease).",
      "key": "5357e7a44b01146dac837476598981f0",
      "line": 246,
      "relation": "association",
      "source": 19,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "0588633d3b6ac7165b2ee0a500a19b5a",
      "line": 219,
      "relation": "increases",
      "source": 36,
      "target": 44
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "83f843f965f6216234a23639d939bb2e",
      "line": 220,
      "relation": "increases",
      "source": 36,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "MRI in patients with small vessel cerebrovascular disease, other inflammatory disorders, and non-inflammatory disorders affecting white matter (tables 1, 2), and even in healthy people (especially in older age groups), might show brain lesions that fulfil MRI criteria for multiple sclerosis.[21–24]",
      "key": "bd7517517d3510d2a54eefa6df197916",
      "line": 221,
      "relation": "increases",
      "source": 36,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "These disorders include several closely related idiopathic inflammatory CNS diseases (tables 1, 2), along with a range of other disorders that can involve white matter (eg, inherited leukodystrophies, vasculopathies, and metabolic disorders), and other neuroinflammatory diseases (eg, sarcoidosis, vasculitis, and Behcet’s disease).",
      "key": "b20af435cca84c1963ee1669c61d46f1",
      "line": 245,
      "relation": "association",
      "source": 36,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "These disorders include several closely related idiopathic inflammatory CNS diseases (tables 1, 2), along with a range of other disorders that can involve white matter (eg, inherited leukodystrophies, vasculopathies, and metabolic disorders), and other neuroinflammatory diseases (eg, sarcoidosis, vasculitis, and Behcet’s disease).",
      "key": "13e6b49dea6dec80c261cd5168efb2fd",
      "line": 241,
      "relation": "association",
      "source": 56,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "These disorders include several closely related idiopathic inflammatory CNS diseases (tables 1, 2), along with a range of other disorders that can involve white matter (eg, inherited leukodystrophies, vasculopathies, and metabolic disorders), and other neuroinflammatory diseases (eg, sarcoidosis, vasculitis, and Behcet’s disease).",
      "key": "a5c839c5ba07f5ef3b464d3806f739fa",
      "line": 242,
      "relation": "association",
      "source": 22,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "These disorders include several closely related idiopathic inflammatory CNS diseases (tables 1, 2), along with a range of other disorders that can involve white matter (eg, inherited leukodystrophies, vasculopathies, and metabolic disorders), and other neuroinflammatory diseases (eg, sarcoidosis, vasculitis, and Behcet’s disease).",
      "key": "8f2fd9071d7e29bece87512bd2c72635",
      "line": 243,
      "relation": "association",
      "source": 66,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "These disorders include several closely related idiopathic inflammatory CNS diseases (tables 1, 2), along with a range of other disorders that can involve white matter (eg, inherited leukodystrophies, vasculopathies, and metabolic disorders), and other neuroinflammatory diseases (eg, sarcoidosis, vasculitis, and Behcet’s disease).",
      "key": "a5c788bd1cda696fb0f94ec4845929f3",
      "line": 244,
      "relation": "association",
      "source": 53,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Acute disseminated encephalomyelitis is an inflammatory demyelinating disorder of the CNS, distinct from multiple sclerosis, that occurs mainly in children and is rare in adults",
      "key": "0edda0345029f36112f31fb9bdbfc414",
      "line": 253,
      "relation": "increases",
      "source": 17,
      "target": 40
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "CSF findings include a lymphocytic pleocytosis and raised protein.",
      "key": "5f30f57ebe191b62a076d4583e5d4bfb",
      "line": 259,
      "relation": "increases",
      "source": 17,
      "target": 73
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "CSF findings include a lymphocytic pleocytosis and raised protein.",
      "key": "4286081b6b17d64856a44ac3ab6cc2aa",
      "line": 260,
      "relation": "increases",
      "source": 17,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": " The clinical, imaging, and laboratory features of acute disseminated encephalomyelitis and multiple sclerosis overlap and diagnostic criteria emphasise the requirement of encephalopathy (altered level of consciousness, behavioural, or cognitive change) in making the diagnosis of acute disseminated encephalomyelitis (appendix). [32] ",
      "key": "713dbc16d07dcdd91a40adddde68eadb",
      "line": 266,
      "relation": "increases",
      "source": 17,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": " The clinical, imaging, and laboratory features of acute disseminated encephalomyelitis and multiple sclerosis overlap and diagnostic criteria emphasise the requirement of encephalopathy (altered level of consciousness, behavioural, or cognitive change) in making the diagnosis of acute disseminated encephalomyelitis (appendix). [32] ",
      "key": "288d67521d4f3a907cd8883541cf65e5",
      "line": 267,
      "relation": "association",
      "source": 17,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": " The clinical, imaging, and laboratory features of acute disseminated encephalomyelitis and multiple sclerosis overlap and diagnostic criteria emphasise the requirement of encephalopathy (altered level of consciousness, behavioural, or cognitive change) in making the diagnosis of acute disseminated encephalomyelitis (appendix). [32] ",
      "key": "7b3c395e08c5fecdcc05ad3b0fee0c34",
      "line": 268,
      "relation": "association",
      "source": 17,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": " The clinical, imaging, and laboratory features of acute disseminated encephalomyelitis and multiple sclerosis overlap and diagnostic criteria emphasise the requirement of encephalopathy (altered level of consciousness, behavioural, or cognitive change) in making the diagnosis of acute disseminated encephalomyelitis (appendix). [32] ",
      "key": "d9010387a2ebccaa8fc1a387e57a17c5",
      "line": 269,
      "relation": "association",
      "source": 17,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": " The clinical, imaging, and laboratory features of acute disseminated encephalomyelitis and multiple sclerosis overlap and diagnostic criteria emphasise the requirement of encephalopathy (altered level of consciousness, behavioural, or cognitive change) in making the diagnosis of acute disseminated encephalomyelitis (appendix). [32] ",
      "key": "904dd2932803ce4ea87085a3de9dda38",
      "line": 267,
      "relation": "association",
      "source": 70,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "db": "PubMed",
        "db_id": "27889190",
        "db_name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "first": "Brownlee WJ",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": " The clinical, imaging, and laboratory features of acute disseminated encephalomyelitis and multiple sclerosis overlap and diagnostic criteria emphasise the requirement of encephalopathy (altered level of consciousness, behavioural, or cognitive change) in making the diagnosis of acute disseminated encephalomyelitis (appendix). [32] ",
      "key": "27fe0219372c7cb097c8403f27b024be",
      "line": 268,
      "relation": "association",
      "source": 2,
      "target": 17
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(MESH:\"Oligoclonal Bands\")",
      "concept": {
        "name": "Oligoclonal Bands",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f30f1fe38ef6de12e64d19b9485074f0"
    },
    {
      "bel": "a(NCIT:C28381)",
      "concept": {
        "name": "C28381",
        "namespace": "NCIT"
      },
      "function": "Abundance",
      "id": "e8369a91af64715378d744f2f7574ec2"
    },
    {
      "bel": "bp(GO:behavior)",
      "concept": {
        "name": "behavior",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "77f1822074b59deb82cc4661eb6d5aa5"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "bp(MESH:\"Lymphocyte Count\")",
      "concept": {
        "name": "Lymphocyte Count",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "1524717e3441737493010574850f1ce7"
    },
    {
      "bel": "bp(MESH:\"Postural Balance\")",
      "concept": {
        "name": "Postural Balance",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "1f8c5ccf14e77bb7ecd1ebe53f2ab3d6"
    },
    {
      "bel": "bp(MESH:\"Vision, Ocular\")",
      "concept": {
        "name": "Vision, Ocular",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "b2d2eeef24c19bd5e81b58eb4b551a74"
    },
    {
      "bel": "bp(MESH:Sensation)",
      "concept": {
        "name": "Sensation",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "e2f410e33dfaed08d11039c53c9b3863"
    },
    {
      "bel": "complex(GO:\"IgG immunoglobulin complex\")",
      "concept": {
        "name": "IgG immunoglobulin complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "ef18815499d29f37c149ceb12b725d7f"
    },
    {
      "bel": "complex(complex(GO:\"IgG immunoglobulin complex\"), p(HGNC:AQP4))",
      "function": "Complex",
      "id": "898c4318ebd556db92f972836bd05ea6",
      "members": [
        {
          "bel": "complex(GO:\"IgG immunoglobulin complex\")",
          "concept": {
            "name": "IgG immunoglobulin complex",
            "namespace": "GO"
          },
          "function": "Complex",
          "id": "ef18815499d29f37c149ceb12b725d7f"
        },
        {
          "bel": "p(HGNC:AQP4)",
          "concept": {
            "name": "AQP4",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7baf9b0141df53566fb1b4733d804b4b"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:AQP4), p(MESH:\"Immunoglobulin G\"))",
      "function": "Complex",
      "id": "551c9f3a76fcf984279a90e265b272bf",
      "members": [
        {
          "bel": "p(HGNC:AQP4)",
          "concept": {
            "name": "AQP4",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7baf9b0141df53566fb1b4733d804b4b"
        },
        {
          "bel": "p(MESH:\"Immunoglobulin G\")",
          "concept": {
            "name": "Immunoglobulin G",
            "namespace": "MESH"
          },
          "function": "Protein",
          "id": "0552597810550378b083a4247508e495"
        }
      ]
    },
    {
      "bel": "p(HGNC:AQP4)",
      "concept": {
        "name": "AQP4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7baf9b0141df53566fb1b4733d804b4b"
    },
    {
      "bel": "p(MESH:\"Immunoglobulin G\")",
      "concept": {
        "name": "Immunoglobulin G",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "0552597810550378b083a4247508e495"
    },
    {
      "bel": "p(MESH:Proteins)",
      "concept": {
        "name": "Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "5f95843f75d793290da323632314ec25"
    },
    {
      "bel": "path(CONSO:neuroinflammation)",
      "concept": {
        "name": "neuroinflammation",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "b264621022ed4df78748c6c4e198145d"
    },
    {
      "bel": "path(DOID:\"Behcet's disease\")",
      "concept": {
        "name": "Behcet's disease",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "9b542a00a948b9912c9a6b289d0e40e8"
    },
    {
      "bel": "path(DOID:\"Sjogren's syndrome\")",
      "concept": {
        "name": "Sjogren's syndrome",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "22bff15e006a40c3d7ed5f2278fae119"
    },
    {
      "bel": "path(DOID:\"acute disseminated encephalomyelitis\")",
      "concept": {
        "name": "acute disseminated encephalomyelitis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "ab1aa67420945ff64d7bda1dbabc9e92"
    },
    {
      "bel": "path(DOID:\"antiphospholipid syndrome\")",
      "concept": {
        "name": "antiphospholipid syndrome",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "22466e24359d1ad9d1872b81473b28db"
    },
    {
      "bel": "path(DOID:\"central nervous system vasculitis\")",
      "concept": {
        "name": "central nervous system vasculitis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "de71718c86e06a6da1960d193499058f"
    },
    {
      "bel": "path(DOID:\"cerebellar ataxia\")",
      "concept": {
        "name": "cerebellar ataxia",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "fae7082cd70b95adcbce69c2fefb5dfe"
    },
    {
      "bel": "path(DOID:\"internuclear ophthalmoplegia\")",
      "concept": {
        "name": "internuclear ophthalmoplegia",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "46e6d6d7b9538ecda69df9ed53e544c3"
    },
    {
      "bel": "path(DOID:\"leukoencephalopathy with vanishing white matter\")",
      "concept": {
        "name": "leukoencephalopathy with vanishing white matter",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "78645328065ff39353126b14713372d7"
    },
    {
      "bel": "path(DOID:\"multiple sclerosis\")",
      "concept": {
        "name": "multiple sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "828e65d53fe5c29b364f79cfd5304f90"
    },
    {
      "bel": "path(DOID:\"neuromyelitis optica\")",
      "concept": {
        "name": "neuromyelitis optica",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "f639ff50800e42cbf0d8b6e0386b196f"
    },
    {
      "bel": "path(DOID:\"optic neuritis\")",
      "concept": {
        "name": "optic neuritis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "791036b0fa3041ed717e835743f78526"
    },
    {
      "bel": "path(DOID:\"pathologic nystagmus\")",
      "concept": {
        "name": "pathologic nystagmus",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "0acb61753b6921bb8a71831f19fad463"
    },
    {
      "bel": "path(DOID:\"primary progressive multiple sclerosis\")",
      "concept": {
        "name": "primary progressive multiple sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "bc354c4df683e76d8f33dad953c46827"
    },
    {
      "bel": "path(DOID:\"relapsing-remitting multiple sclerosis\")",
      "concept": {
        "name": "relapsing-remitting multiple sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "b21b34dd5c948d6330eceb5f4eb9649f"
    },
    {
      "bel": "path(DOID:\"secondary progressive multiple sclerosis\")",
      "concept": {
        "name": "secondary progressive multiple sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "38f0567d9ceb0ade6bf93de56a897396"
    },
    {
      "bel": "path(DOID:\"systemic lupus erythematosus\")",
      "concept": {
        "name": "systemic lupus erythematosus",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "055b0e91361e8cdf7def57c81e495fe1"
    },
    {
      "bel": "path(DOID:\"trigeminal neuralgia\")",
      "concept": {
        "name": "trigeminal neuralgia",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "3e455674c6b5ffa1cfd36f469672146f"
    },
    {
      "bel": "path(DOID:CADASIL)",
      "concept": {
        "name": "CADASIL",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "a40374fa99a69249ee6eaafa9109e39b"
    },
    {
      "bel": "path(DOID:dementia)",
      "concept": {
        "name": "dementia",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "12dcaf8ab5101babb7dc7b3b88e591ed"
    },
    {
      "bel": "path(DOID:migraine)",
      "concept": {
        "name": "migraine",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "0b5e2adad55000b6964c700415e4a1f1"
    },
    {
      "bel": "path(DOID:myelitis)",
      "concept": {
        "name": "myelitis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "1452aeef9341de994a8094343ffd1b03"
    },
    {
      "bel": "path(DOID:neurosarcoidosis)",
      "concept": {
        "name": "neurosarcoidosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "7caaa75c6bf0d2d53e8b1309a64eee79"
    },
    {
      "bel": "path(DOID:thrombosis)",
      "concept": {
        "name": "thrombosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "3ad69318d896af3fb5cf08161fb3c569"
    },
    {
      "bel": "path(HP:\"Abnormality of the cerebrospinal fluid\")",
      "concept": {
        "name": "Abnormality of the cerebrospinal fluid",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "f944cd8a5b13c53d98ac306e8b3cd54d"
    },
    {
      "bel": "path(HP:\"Asymmetric limb muscle stiffness\")",
      "concept": {
        "name": "Asymmetric limb muscle stiffness",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "6b2f78f3b31721c34d3120231c467e30"
    },
    {
      "bel": "path(HP:\"CNS demyelination\")",
      "concept": {
        "name": "CNS demyelination",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "fb7670f43e6511eda6fbd0b0517820a6"
    },
    {
      "bel": "path(HP:\"Facial palsy\")",
      "concept": {
        "name": "Facial palsy",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "7f71be0c6b5e3789ce455244247c5442"
    },
    {
      "bel": "path(HP:\"Lhermitte's sign\")",
      "concept": {
        "name": "Lhermitte's sign",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "f6e9524aa638f6564377a358b67ef730"
    },
    {
      "bel": "path(HP:\"Nausea and vomiting\")",
      "concept": {
        "name": "Nausea and vomiting",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "20f1a69bd22211b34f4abb46cb4889c1"
    },
    {
      "bel": "path(HP:\"Optic neuropathy\")",
      "concept": {
        "name": "Optic neuropathy",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "0018237657eff3f3127b0bbd5f422820"
    },
    {
      "bel": "path(HP:Ataxia)",
      "concept": {
        "name": "Ataxia",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "da410da3fc48fdd33615f068787f9705"
    },
    {
      "bel": "path(HP:Encephalopathy)",
      "concept": {
        "name": "Encephalopathy",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "2cb879eae1dda03ac9354f409cc729da"
    },
    {
      "bel": "path(HP:Headache)",
      "concept": {
        "name": "Headache",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "a24ae0bd1e3980c71af01ddc357c55ad"
    },
    {
      "bel": "path(HP:Hemiparesis)",
      "concept": {
        "name": "Hemiparesis",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "9abd8c6c941cad4d9ecf8178e74ccfd4"
    },
    {
      "bel": "path(HP:Myelopathy)",
      "concept": {
        "name": "Myelopathy",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "0e8e666aba2c122916e2509d0a34946d"
    },
    {
      "bel": "path(HP:Paraparesis)",
      "concept": {
        "name": "Paraparesis",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "1473481a5108006e7f1d983becf8ef21"
    },
    {
      "bel": "path(HP:Seizures)",
      "concept": {
        "name": "Seizures",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "d16a1b8e9472ae9547c2f8f1d30e4676"
    },
    {
      "bel": "path(MESH:\"Abortion, Habitual\")",
      "concept": {
        "name": "Abortion, Habitual",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "8a5b83fd3f50cfd3937911eaf582be52"
    },
    {
      "bel": "path(MESH:\"Brain Diseases, Metabolic\")",
      "concept": {
        "name": "Brain Diseases, Metabolic",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "eefae99b5519399cba8bcd61b7f2190a"
    },
    {
      "bel": "path(MESH:\"Brain Injuries\")",
      "concept": {
        "name": "Brain Injuries",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "1ac8fcaca36bf2aee3bf5c9dfa8eca2c"
    },
    {
      "bel": "path(MESH:\"Brain Stem Infarctions\")",
      "concept": {
        "name": "Brain Stem Infarctions",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "0cd16c8aebc97a34c4fc79548a428c63"
    },
    {
      "bel": "path(MESH:\"Central Nervous System Diseases\")",
      "concept": {
        "name": "Central Nervous System Diseases",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "1114043399ecabdf9c223540cf1dade5"
    },
    {
      "bel": "path(MESH:\"Demyelinating Diseases\")",
      "concept": {
        "name": "Demyelinating Diseases",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "fd58854d02026d9f5fa3d1ebdeaee004"
    },
    {
      "bel": "path(MESH:\"Erectile Dysfunction\")",
      "concept": {
        "name": "Erectile Dysfunction",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "9aaa174b28f278d9661b953ad3e8c9d8"
    },
    {
      "bel": "path(MESH:\"Mobility Limitation\")",
      "concept": {
        "name": "Mobility Limitation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "583cbcb6ee603c1508c833d775686f37"
    },
    {
      "bel": "path(MESH:\"Neurologic Manifestations\")",
      "concept": {
        "name": "Neurologic Manifestations",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "0bf18f7ddf2f4951a317157d5e47cd2d"
    },
    {
      "bel": "path(MESH:\"Optic Atrophy, Hereditary, Leber\")",
      "concept": {
        "name": "Optic Atrophy, Hereditary, Leber",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "8f615bf0665c6b47e7a369f98a34de28"
    },
    {
      "bel": "path(MESH:\"Oral Ulcer\")",
      "concept": {
        "name": "Oral Ulcer",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "81c1ba872a7d5427d1ef3be715f4de1a"
    },
    {
      "bel": "path(MESH:\"Spinal Cord Injuries\")",
      "concept": {
        "name": "Spinal Cord Injuries",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "0221bb9b1aa880969f99e2de78e60adc"
    },
    {
      "bel": "path(MESH:\"Susac Syndrome\")",
      "concept": {
        "name": "Susac Syndrome",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "1456614a45c952eb8164e82a9f9d3355"
    },
    {
      "bel": "path(MESH:\"Vascular Diseases\")",
      "concept": {
        "name": "Vascular Diseases",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "7146a5e45df24b1d804c361eb0d9878a"
    },
    {
      "bel": "path(MESH:\"Vasculopathy, Retinal, With Cerebral Leukodystrophy\")",
      "concept": {
        "name": "Vasculopathy, Retinal, With Cerebral Leukodystrophy",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "6d55b95c63e68e6e749d1666cc088174"
    },
    {
      "bel": "path(MESH:\"Vision, Low\")",
      "concept": {
        "name": "Vision, Low",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "a2d43663f014f349a8143122b4b1afb1"
    },
    {
      "bel": "path(MESH:\"Visual Perception\")",
      "concept": {
        "name": "Visual Perception",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "44e6b3d2d9b3148faa351a5316606550"
    },
    {
      "bel": "path(MESH:\"Wounds and Injuries\")",
      "concept": {
        "name": "Wounds and Injuries",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "1b05ca7def743c6a806d2347dcc495d3"
    },
    {
      "bel": "path(MESH:Consciousness)",
      "concept": {
        "name": "Consciousness",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "8a3ba14c6dfb796c404a4117b80f2fc4"
    },
    {
      "bel": "path(MESH:Deafness)",
      "concept": {
        "name": "Deafness",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "6cb80cb72c104d4f8b94f65055d66dc4"
    },
    {
      "bel": "path(MESH:Inflammation)",
      "concept": {
        "name": "Inflammation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "10cd96fd4056a5e6c27264e0130e89f9"
    },
    {
      "bel": "path(MESH:Leukocytosis)",
      "concept": {
        "name": "Leukocytosis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "54dfc757174db3732ef0729cd7c273be"
    },
    {
      "bel": "path(MESH:Ulcer)",
      "concept": {
        "name": "Ulcer",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "9bea322f6d28bb0697aacae6b8b69b62"
    },
    {
      "bel": "path(NCIT:C21007)",
      "concept": {
        "name": "C21007",
        "namespace": "NCIT"
      },
      "function": "Pathology",
      "id": "567e9969f4afcd1025c406a11302125a"
    }
  ]
}